Abstract:Objective:To study the effects of continuous blood purification(CBP)in the treatment of 1 692 critical patients retrospectively and analyze the influencing factors of prognosis.Methodology:From Jan.1998 to Mar.2007,a total of 1 692 critical patients were treated with CBP in Jingling Hospital.The clinical data was collected:(1)General conditions:sex,age and original disease;(2)Clinical status prior to CBP:indications of CBP,APACHE Ⅱ score,SAPS Ⅱ score,number of organ dysfunction,complications,and the percentage of patients with vasoactive agents and mechanical ventilation;(3)Technique and method of CBP:modality,dosage,and vascular access of CBP,category of anticoagulant and membrane of hemofilter used in CBP;(4)Outcomes:the individual predicted risk of death was calculated form the SAPS Ⅱ scores of each patient.Results:(1)They were 1 088 males and 604 females,with an average of(46.9±19.6)years old(3.5-94,median 46).1 107 cases(65.43%)were admitted for medical reasons and 585(34.57%)for surgical reasons.(2)Three main indications of CBP were azotemia(60.46%),oliguria/anuria(39.07%)and refractory organ edema(especially lung)/nutritional support in patients with or at risk of pulmonary edema/ARDS(16.13%).(3)Continuous high-volume hemofiltration(HVHF)(66.55%)and continuous veno-venous hemofiltration(CVVH)(27.30%)were the main modality of CBP.A double-lumen catheter was used in most of patients through the internal jugular vein(64.72%)and femoral vein(30.91%).Polysulfone(78.72%)and polyacrylonitrile(15.77%)were the most common used membranes.57.21% of cases were anticoagulated with low molecular weight heparin(LMWH)combined with citrate acid,and 23.40% with LMWH only.(4)Except for 94 cases(5.56%)quitted for economic reasons,800 cases(47.28%)were cured and 458(27.07%)were improved.The total effective(cure and improve)rate was 74.6%,340 cased died,the mortality was 20.1%,which was lower than that the predicted in-hospital mortality of 29.5%.(5)The M/F ratio was much higher in the non-survivals,with an average of(55.8±21.1)years old vs(44.8±18.8)in the survivals(P0.01).The clinical condition of non-survivals were more severe before CBP:with higher APACHE Ⅱ scores and SAPS Ⅱ scores,more patients complicated with hypotension/shock,bleeding and infection/sepsis,more patients treated with vasoactive agents and mechanical ventilation,and more organ function were injured.Conclusion:The outcome of critical ill patients was significantly improved by CBP,the mortality was decreased.

Double filtration plasmapheresis and immunoadsorption:new model of continuous blood purification

Chromatographic technology in antibody purification and its progress

State-of-the-art Technocology in Blood Purification at Present

Zwitterionic Polymers As High-Performance Coatings for Hemoperfusion Adsorbents and Their Chemisorption of Protein-Bound Toxins Through Computational Simulations

APPLICATION OF MEMBRANE SEPARATION TECHNOLOGY IN THE PREPARATION OF ULTRAPURE DIALYSATE

The effect of continuous blood purification on P38MAPK signaling pathway in patients with multiple organ dysfunction syndrome

Clinical Study of the Influence of Continuous Hemofiltration on Gastrointestinal Dysfunction of the Patients with Intra-Abdominal Hypertension

Continuous Blood Purification in the Treatment of 1692 Critical Patients:A Retrospective Study

Application of continuous blood purification in children with severe sepsis

Nursing of Continuous Blood Purification in Patients with Abdominal Infections in Surgical Intensive Care Unit

Structure design and performance study on filtration-adsorption bifunctional blood purification membrane

Evaluation of continuous blood purification in patients with urosepsis caused by ureteral calculi and heart failure after catheterization

Progress in Clinical Application of Blood Purification Technology in the Treatment of Acute Poisoning

Recent trends in therapeutic application of engineered blood purification materials for kidney disease

Research on Nursing Effect of Individualized Nursing Intervention on Critically Ill Patients with Continuous Blood Purification

Present condition of scientific research in blood purification area by analyzing the articles of 《Chinese Journal of Blood Purification》

Clinical Application of 153 Times Membrane Plasmapheresis

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].

Murine chemokine gene expression in rejecting pig proislet xenografts.

Recent advances in blood toxin removal technology

Research progress on blood compatibility of hemoperfusion adsorbent materials